Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations.

Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations. — المؤلف: Moon, Jai-Hee — British journal of cancer 20200228

المؤلف
Moon, Jai-Hee
النشر
British journal of cancer 20200228
الوصف
941-951 p.
الموضوعات
Acetamides؛ Animals؛ Biomarkers, Pharmacological؛ Biomarkers, Tumor؛ Class I Phosphatidylinositol 3-Kinases؛ Colonic Neoplasms؛ Drug Resistance, Viral؛ Humans